Recursion Pharmaceuticals Inc (RXRX) — Capital Reinvestment Ratio

Latest as of March 2022: 0.06x

Recursion Pharmaceuticals Inc (RXRX) has a Capital Reinvestment Ratio of 0.06x as of March 2022, meaning it reinvests 0% of its operating cash flow ($77.39 Million) in capital expenditures ($4.34 Million). Check tangible equity quality of Recursion Pharmaceuticals Inc to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.06x

Capex / Operating Cash Flow

Operating Cash Flow

$77.39 Million

USD

Capital Expenditures

$4.34 Million

USD

Data as of

Mar 2022

Most recent filing

Annual Capital Reinvestment Ratio for Recursion Pharmaceuticals Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Recursion Pharmaceuticals Inc from None to None. See Recursion Pharmaceuticals Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow